Compounds > lysine
Page last updated: 2024-08-17

lysine and Granulocytic Leukemia, Chronic

lysine has been researched along with Granulocytic Leukemia, Chronic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Chen, P; Gao, L; Sun, J; Tang, G; Wang, W; Xiang, M; Xu, M; Yao, SQ; Zhang, CJ; Zhang, ZM; Zhu, C1
Flores-Alvarez, LJ; Jiménez-Alcántar, P; López-Meza, JE; Ochoa-Zarzosa, A1
Anantharajan, J; Baburajendran, N; Foo, K; Joy, JK; Keller, TH; Kwek, PZ; Li, R; Liu, B; Poulsen, A; Quach, D; Retna, P; Tang, G; Tee, DHY; Wee, JLK; Yang, WQ; Yao, SQ; Zhang, CJ1
Dubey, KD; Ojha, RP1
Bassan, R; Bussini, A; Castagnetti, F; Gnani, A; Intermesoli, T; Rosti, G; Soverini, S; Spinelli, O1
Bainbridge, M; DeCoteau, JF; Dong, WF; Geyer, CR; Huang, S; Hull, A; Lowsky, R; Pastural, E; Pearson, D; Takahashi, N1
Delgado, C; Fisher, D; Francis, GE; Irvine, AE; Knüsli, C; Malik, F1

Other Studies

7 other study(ies) available for lysine and Granulocytic Leukemia, Chronic

ArticleYear
Cell-Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR-ABL Kinase.
    Angewandte Chemie (International ed. in English), 2022, 06-27, Volume: 61, Issue:26

    Topics: Fusion Proteins, bcr-abl; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysine; Protein Kinase Inhibitors; Pyrimidines

2022
The Antimicrobial Peptide γ-Thionin from Habanero Chile (
    Molecules (Basel, Switzerland), 2023, Apr-23, Volume: 28, Issue:9

    Topics: Animals; Antimicrobial Peptides; Antineoplastic Agents; Apoptosis; Capsicum; Caspases; Chile; Defensins; Epigenesis, Genetic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Lysine; Peptides; Thionins

2023
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.
    Angewandte Chemie (International ed. in English), 2021, 07-26, Volume: 60, Issue:31

    Topics: Drug Design; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysine; Molecular Structure; Protein Kinase Inhibitors

2021
Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex.
    Journal of molecular modeling, 2012, Volume: 18, Issue:5

    Topics: Alanine; Benzamides; Binding Sites; Glutamic Acid; Humans; Hydrogen Bonding; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ligands; Lysine; Molecular Dynamics Simulation; Mutagenesis; Piperazines; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Salts; Thermodynamics

2012
Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib.
    Leukemia research, 2012, Volume: 36, Issue:1

    Topics: Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Pharmacological; Biomarkers, Tumor; Dasatinib; Female; Fusion Proteins, bcr-abl; Glutamic Acid; Humans; Imatinib Mesylate; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysine; Mutation, Missense; Phenylalanine; Piperazines; Polymorphism, Single Nucleotide; Pyrimidines; Remission Induction; Thiazoles; Time Factors; Treatment Outcome

2012
RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines.
    Oncogene, 2007, Mar-08, Volume: 26, Issue:11

    Topics: DNA-Binding Proteins; Gene Expression Regulation; Histone-Lysine N-Methyltransferase; Histones; Humans; Insulin-Like Growth Factor I; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysine; Methylation; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Signal Transduction; Transcription Factors

2007
Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity.
    Experimental hematology, 1992, Volume: 20, Issue:8

    Topics: Animals; Biological Availability; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Chromatography, Liquid; Electrophoresis, Polyacrylamide Gel; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysine; Male; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Thymidine; Tritium; Tumor Cells, Cultured

1992